ICD-10 Coding for Amyloidosis(E85.81, E85.82)
Complete ICD-10-CM coding and documentation guide for Amyloidosis. Includes clinical validation requirements, documentation requirements, and coding pitfalls.
Also known as:
Related ICD-10 Code Ranges
Complete code families applicable to Amyloidosis
E85Primary Range
Amyloidosis
This range includes all types of amyloidosis, which are characterized by abnormal protein deposits in tissues and organs.
Code Comparison: When to Use Each Code
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| E85.81 | AL amyloidosis | Use when AL amyloidosis is confirmed with organ involvement. |
|
| E85.82 | Hereditary ATTR amyloidosis | Use for confirmed ATTR amyloidosis with genetic testing. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information: ICD-10 code for AL amyloidosis
Essential facts and insights about Amyloidosis
Primary ICD-10-CM Codes for amyloidosis
Decision Criteria
clinical Criteria
- Confirmed AL amyloidosis with organ involvement.
Applicable To
- Primary systemic amyloidosis
Excludes
- Secondary systemic amyloidosis (E85.89)
Clinical Validation Requirements
- Light chain amyloid confirmed by serum FLC ratio >6.0 and bone marrow plasmacytosis ≥10%
Code-Specific Risks
- Risk of incorrect coding if organ involvement is not specified.
Coding Notes
- Ensure organ involvement is documented to support coding.
E85.82 - Hereditary ATTR amyloidosis
Use for confirmed ATTR amyloidosis with genetic testing.
Applicable To
- Familial amyloid polyneuropathy
Excludes
- AL amyloidosis (E85.81)
Clinical Validation Requirements
- Grade 2-3 myocardial uptake on 99mTc-PYP SPECT with H/CL ratio >1.5
Coding Notes
Document genetic testing results to support coding.
Ancillary Codes
Additional codes that should be used in conjunction with the main diagnosis codes when applicable.
Documentation & Coding Risks
Avoid these common documentation and coding issues when documenting Amyloidosis to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code E85.81.
Impact
Clinical: Inadequate treatment planning., Regulatory: Non-compliance with documentation standards., Financial: Potential claim denials.
Mitigation Strategy
Use templates to ensure all elements are documented., Regular training on documentation standards.
Impact
Reimbursement: Incorrect coding can lead to claim denials., Compliance: Non-compliance with coding guidelines., Data Quality: Poor data quality affecting patient records.
Mitigation Strategy
Always specify the subtype of amyloidosis when known.
Impact
Audits may target incorrect use of unspecified codes when specific types are documented.
Mitigation Strategy
Ensure all documentation specifies the type and organ involvement.
Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.
Frequently Asked Questions
Common questions about ICD-10 coding for Amyloidosis, with expert answers to help guide accurate code selection and documentation.
Documentation Templates for Amyloidosis
Use these documentation templates to ensure complete and accurate documentation for Amyloidosis. These templates include all required elements for proper coding and billing.
Cardiac amyloidosis with ATTR
Specialty: CardiologyRequired Elements
- Type of amyloidosis
- Diagnostic confirmation
- Organ involvement
Example Documentation
Examples: Poor vs. Good Documentation
Poor Documentation Example
Good Documentation Example
Explanation
Need help with ICD-10 coding for Amyloidosis? Ask your questions below.